Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Diebold

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2025
Targeting CD38 in Antibody-Mediated RejectionKatharina A Mayer, Klemens Budde, Matthias Diebold, et al.
Transplantation|August 28, 2024
Chronic Rejection After Kidney TransplantationMatthias Diebold, Katharina A Mayer, Luis Hidalgo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2025
Antibody-mediated rejection-treatment standardGeorg A Böhmig, Maarten Naesens, Ondrej Viklicky, et al.
BMC Pulmonary Medicine|August 14, 2014
Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort studyDaniel Franzen, Matthias Diebold, Alex Soltermann, et al.
Expert Opinion on Investigational Drugs|February 10, 2025
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluationKatharina A Mayer, Klemens Budde, Martina Schatzl, et al.
Swiss Medical Weekly|August 25, 2020
Mortality prediction in acute heart failure: scores or biomarkers?Desiree Wussler, Eleni Michou, Maria Belkin, et al.
Swiss Medical Weekly|August 9, 2023
Outcome of kidney transplantation from senior deceased donors: a single centre studyKris Magerl, Matthias Diebold, Caroline Wehmeier, et al.
Respiratory Research|March 4, 2017
Low tissue levels of miR-125b predict malignancy in solitary fibrous tumors of the pleuraMatthias Brock, Selma Hottinger, Matthias Diebold, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 3, 2024
Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection: Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional DeclineCarsten T Herz, Matthias Diebold, Alexander Kainz, et al.
Swiss Medical Weekly|June 26, 2025
Bleeding risk after native and transplant kidney biopsy - a single-centre observational studyCéline Fontana, Matthias Diebold, Patrizia Amico, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2025
Targeting CD38 in Antibody-Mediated RejectionKatharina A Mayer, Klemens Budde, Matthias Diebold, et al.
Transplantation|August 28, 2024
Chronic Rejection After Kidney TransplantationMatthias Diebold, Katharina A Mayer, Luis Hidalgo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2025
Antibody-mediated rejection-treatment standardGeorg A Böhmig, Maarten Naesens, Ondrej Viklicky, et al.
BMC Pulmonary Medicine|August 14, 2014
Determinants of outcome of solitary fibrous tumors of the pleura: an observational cohort studyDaniel Franzen, Matthias Diebold, Alex Soltermann, et al.
Expert Opinion on Investigational Drugs|February 10, 2025
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluationKatharina A Mayer, Klemens Budde, Martina Schatzl, et al.
Swiss Medical Weekly|August 25, 2020
Mortality prediction in acute heart failure: scores or biomarkers?Desiree Wussler, Eleni Michou, Maria Belkin, et al.
Swiss Medical Weekly|August 9, 2023
Outcome of kidney transplantation from senior deceased donors: a single centre studyKris Magerl, Matthias Diebold, Caroline Wehmeier, et al.
Respiratory Research|March 4, 2017
Low tissue levels of miR-125b predict malignancy in solitary fibrous tumors of the pleuraMatthias Brock, Selma Hottinger, Matthias Diebold, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 3, 2024
Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection: Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional DeclineCarsten T Herz, Matthias Diebold, Alexander Kainz, et al.
Swiss Medical Weekly|June 26, 2025
Bleeding risk after native and transplant kidney biopsy - a single-centre observational studyCéline Fontana, Matthias Diebold, Patrizia Amico, et al.
Pageof 5